Other superficial mycoses
ICD-10 B36.8 is a billable code used to indicate a diagnosis of other superficial mycoses.
B36.8 refers to a category of fungal infections that affect the skin and mucous membranes, which are not classified under more specific mycoses. These infections can be caused by various fungi, including dermatophytes, yeasts, and non-dermatophyte molds. Common manifestations include tinea (ringworm), candidiasis, and other superficial fungal infections that do not fit neatly into other categories. Patients may present with symptoms such as itching, redness, scaling, and lesions on the skin or mucous membranes. The diagnosis is typically made through clinical evaluation and may be confirmed with laboratory tests, such as KOH preparation or fungal cultures. Treatment often involves topical or systemic antifungal medications, depending on the severity and extent of the infection. In immunocompromised patients, such as those with HIV/AIDS, diabetes, or undergoing chemotherapy, these infections can be more severe and may require aggressive treatment. Proper identification and management are crucial to prevent complications and improve patient outcomes.
Detailed descriptions of lesions, location, and symptoms; lab results confirming fungal infection.
Diagnosis and treatment of tinea infections, candidiasis, and other superficial fungal infections.
Ensure accurate documentation of the type of fungal infection and any underlying conditions.
Comprehensive patient history, including immunocompromised status and previous infections.
Management of fungal infections in immunocompromised patients, including treatment adjustments.
Consideration of systemic antifungal therapy and monitoring for complications.
Used to confirm the diagnosis of a fungal infection.
Document the reason for the culture and the clinical findings.
Dermatology may require more detailed documentation of the lesion.
Common treatments include topical antifungals such as clotrimazole or miconazole for localized infections, and systemic antifungals like fluconazole or itraconazole for more extensive or recurrent infections.
